UNSPSC 51162349: Caramiphen/chlorpheniramine/isopropamide/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162349 Caramiphen/chlorpheniramine/isopropamide/phenylpropanolamine is a Commodity code with minimal recent state and local activity directly aligned to its nominal scope. The two recent opportunities tagged to this code involve naloxone procurement and multi-source generic pharmaceuticals through cooperative purchasing, neither of which matches the antihistamine and decongestant combination the code nominally describes. State and local buyers do procure pharmaceuticals through competitive bidding and cooperative vehicles, but the recent record under this specific code does not reflect demand for the active-ingredient combination its name specifies.

Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with responses due July 26, 2023. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. The code shows activity spanning Florida and the upper Midwest, but the mismatch between the code's specified pharmaceutical combination and the actual solicitation scope suggests either miscoding by the issuing bodies or that procurement volumes under this particular active-ingredient formulation are too low to generate tagged opportunities in the recent record.